(Q43278197)

18 November 2017

Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke (English)

1 reference

18 November 2017

2

Megumi Shimodozono

1 reference

18 November 2017

4

Kazumi Kawahira

1 reference

18 November 2017

Shuji Matsumoto

1

1 reference

PubMed ID

19745828

18 November 2017

Ryuji Miyata

series ordinal

3

1 reference

18 November 2017

11 September 2009

1 reference

18 November 2017

Hypertension Research

1 reference

18 November 2017

32

1 reference

18 November 2017

11

1 reference

18 November 2017

1015-1021

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.143

18 November 2017

0 references

cites work

Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Autoregulation of brain circulation in severe arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Hemodynamic influences of losartan on the brain in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Imaging local cerebral blood flow by Xenon-enhanced computed tomography--technical optimization procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Electromyogram-triggered neuromuscular stimulation and stroke motor recovery of arm/hand functions: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Analysis of magnetic resonance imaging (MRI) morphometry and cerebral blood flow in patients with hypoxic-ischemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Differences in acetazolamide vasoreactivity in patients with acute and chronic occlusion of the internal carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced ct cerebral blood flow and transcranial Doppler

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Statistical methods for analysing Barthel scores in trials of poststroke interventions: a review and computer simulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Amlodipine lowers blood pressure without significant effect on cerebral blood flow in hypertensive patients with a history of stroke: a quantitative single photon emission computed tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

The relationship between mental status examination scores and cerebral blood flow in geriatric schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

CT-CBF correlations of cognitive deficits in multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Decreased cerebral blood flow precedes multi-infarct dementia, but follows senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Cerebrovascular aspects of converting-enzyme inhibition I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats.

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FHR.2009.143

21 January 2018

https://api.crossref.org/works/10.1038%2FHR.2009.143

7 January 2021

Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Effect of captopril on the cerebral circulation in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

7 January 2021

Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

7 January 2021

Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

7 January 2021

Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.143

7 January 2021

Identifiers

DOI

10.1038/HR.2009.143

1 reference

18 November 2017

1 reference

PubMed ID

19745828